MECP2 and atypical Rett syndrome: MECP2 was first widely known for its role in Rett syndrome, but recent studies have shown that the role of MECP2 in tumour cells may be dual, that is, tumour‐suppressive or tumour‐promoting, depending on the type of tumour, mutation status and the characteristics of the tumour microenvironment.